If symptoms recur despite repeated pauses or dose reductions, the patients maximum tolerated dose should be accepted as the maintenance dose or switching to a different agent
JCI Insight 5 (6), e133429 (2020)
September 15, 2023 Study Finds Strong Correlation Between Tirzepatide and Gastrointestinal Issues In September 2023, one of many studies confirmed the significant prevalence of gastrointestinal issues with tirzepatide
Always moisturize and use SPF
During the intensive lifestyle intervention lead-in period, lifestyle instruction was delivered 8 times over 12 weeks by a dietician or dietician-equivalent, with all patients receiving instruction to exercise for at least 150 minutes per week and to reduce their caloric intake to approximately 1,200 kcal/day (females) or 1,500 kcal/day (males)
Check out our extensive video library